Literature DB >> 8796570

Mechanism of hepatic uptake of gadoxetate disodium.

H J Weinmann1, H Bauer, T Frenzel, A Mühler, W Ebert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8796570     DOI: 10.1016/s1076-6332(96)80544-7

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


× No keyword cloud information.
  5 in total

1.  Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla.

Authors:  N Verloh; M Haimerl; F Zeman; M Schlabeck; A Barreiros; M Loss; A G Schreyer; C Stroszczynski; C Fellner; P Wiggermann
Journal:  Eur Radiol       Date:  2014-02-16       Impact factor: 5.315

2.  Quantitative evaluation of enhancement patterns in focal solid liver lesions with Gd-EOB-DTPA-enhanced MRI.

Authors:  Michael Haimerl; Max Wächtler; Florian Zeman; Niklas Verloh; Ivan Platzek; Andreas Georg Schreyer; Christian Stroszczynski; Philipp Wiggermann
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

3.  Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation.

Authors:  Niklas Verloh; Kirsten Utpatel; Michael Haimerl; Florian Zeman; Claudia Fellner; Stefan Fichtner-Feigl; Andreas Teufel; Christian Stroszczynski; Matthias Evert; Philipp Wiggermann
Journal:  Sci Rep       Date:  2015-10-19       Impact factor: 4.379

4.  Diagnostic performance of Gd-EOB-DTPA-enhanced MRI for evaluation of liver dysfunction: a multivariable analysis of 3T MRI sequences.

Authors:  Niklas Verloh; Kirsten Utpatel; Florian Zeman; Claudia Fellner; Hans J Schlitt; Martina Müller; Christian Stroszczynski; Matthias Evert; Philipp Wiggermann; Michael Haimerl
Journal:  Oncotarget       Date:  2018-11-20

5.  Assessment of gadoxetate DCE-MRI as a biomarker of hepatobiliary transporter inhibition.

Authors:  Jose L Ulloa; Simone Stahl; James Yates; Neil Woodhouse; J Gerry Kenna; Huw B Jones; John C Waterton; Paul D Hockings
Journal:  NMR Biomed       Date:  2013-04-07       Impact factor: 4.044

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.